BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10659699)

  • 1. Enhanced biological activity of 1alpha,25-dihydroxy-20-epi-vitamin D3, the C-20 epimer of 1alpha,25-dihydroxyvitamin D3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity.
    Siu-Caldera ML; Sekimoto H; Peleg S; Nguyen C; Kissmeyer AM; Binderup L; Weiskopf A; Vouros P; Uskoković MR; Reddy GS
    J Steroid Biochem Mol Biol; 1999 Dec; 71(3-4):111-21. PubMed ID: 10659699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
    Siu-Caldera ML; Clark JW; Santos-Moore A; Peleg S; Liu YY; Uskoković MR; Sharma S; Reddy GS
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):405-12. PubMed ID: 9010346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue specific metabolism of 1alpha,25-dihydroxy-20-epi-vitamin D3 into new metabolites with significant biological activity: studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8).
    Siu-Caldera ML; Rao DS; Astecker N; Weiskopf A; Vouros P; Konno K; Fujishima T; Takayama H; Peleg S; Reddy GS
    J Cell Biochem; 2001; 82(4):599-609. PubMed ID: 11500938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and identification of 1alpha-hydroxy-24-oxovitamin D3 and 1alpha,23-dihydroxy-24-oxovitamin D3: metabolites of 1alpha,24(R)-dihydroxyvitamin D3 produced in rat kidney.
    Weinstein EA; Rao DS; Siu-Caldera ML; Tserng KY; Uskokovic MR; Ishizuka S; Reddy GS
    Biochem Pharmacol; 1999 Dec; 58(12):1965-73. PubMed ID: 10591152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells.
    Rehan VK; Torday JS; Peleg S; Gennaro L; Vouros P; Padbury J; Rao DS; Reddy GS
    Mol Genet Metab; 2002 May; 76(1):46-56. PubMed ID: 12175780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
    Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
    J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed.
    Siu-Caldera ML; Sekimoto H; Weiskopf A; Vouros P; Muralidharan KR; Okamura WH; Bishop J; Norman AW; Uskoković MR; Schuster I; Reddy GS
    Bone; 1999 May; 24(5):457-63. PubMed ID: 10321905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor.
    Messerlian S; Gao X; St-Arnaud R
    J Steroid Biochem Mol Biol; 2000; 72(1-2):29-34. PubMed ID: 10731635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL-60 cells.
    Rao DS; Campbell MJ; Koeffler HP; Ishizuka S; Uskokovic MR; Spagnuolo P; Reddy GS
    Steroids; 2001; 66(3-5):423-31. PubMed ID: 11179751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased biological activity of 20-epi-1,25-dihydroxyvitamin D3 is due to reduced catabolism and altered protein binding.
    Dilworth FJ; Calverley MJ; Makin HL; Jones G
    Biochem Pharmacol; 1994 Mar; 47(6):987-93. PubMed ID: 8147918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 1alpha,25(OH)2D3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation.
    Campbell MJ; Drayson MT; Durham J; Wallington L; Siu-Caldera ML; Reddy GS; Brown G
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):169-83. PubMed ID: 10375029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of 3-epi-1alpha,25-dihydroxyvitamin D3 involved in 1alpha,25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines.
    Masuda S; Kamao M; Schroeder NJ; Makin HL; Jones G; Kremer R; Rhim J; Okano T
    Biol Pharm Bull; 2000 Feb; 23(2):133-9. PubMed ID: 10706373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of selective 20-epi-vitamin D
    Flarakos CC; Weiskopf A; Robinson M; Wang G; Vouros P; Sasso GJ; Uskokovic MR; Reddy GS
    Steroids; 2017 Mar; 119():18-30. PubMed ID: 28089927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor.
    Molnár F; Sigüeiro R; Sato Y; Araujo C; Schuster I; Antony P; Peluso J; Muller C; Mouriño A; Moras D; Rochel N
    PLoS One; 2011 Mar; 6(3):e18124. PubMed ID: 21483824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, identification and biological activity of 24R,25-dihydroxy-3-epi-vitamin D3: a novel metabolite of 24R,25-dihydroxyvitamin D3 produced in rat osteosarcoma cells (UMR 106).
    Kamao M; Tatematsu S; Reddy GS; Hatakeyama S; Sugiura M; Ohashi N; Kubodera N; Okano T
    J Nutr Sci Vitaminol (Tokyo); 2001 Apr; 47(2):108-15. PubMed ID: 11508700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
    Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
    Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
    Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
    J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha,25-Dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1alpha,25-dihydroxyvitamin D3: its production and metabolism in primary human keratinocytes.
    Astecker N; Reddy GS; Herzig G; Vorisek G; Schuster I
    Mol Cell Endocrinol; 2000 Dec; 170(1-2):91-101. PubMed ID: 11162893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.
    Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.